| Literature DB >> 33356612 |
Emily A Erdmann1, Ananya Mahapatra1, Priyanka Mukherjee2, Boyoon Yang3, Heather A Hundley2.
Abstract
Adenosine deaminases that act on RNA (ADARs) are present in all animals and function to both bind double-stranded RNA (dsRNA) and catalyze the deamination of adenosine (A) to inosine (I). As inosine is a biological mimic of guanosine, deamination by ADARs changes the genetic information in the RNA sequence and is commonly referred to as RNA editing. Millions of A-to-I editing events have been reported for metazoan transcriptomes, indicating that RNA editing is a widespread mechanism used to generate molecular and phenotypic diversity. Loss of ADARs results in lethality in mice and behavioral phenotypes in worm and fly model systems. Furthermore, alterations in RNA editing occur in over 35 human pathologies, including several neurological disorders, metabolic diseases, and cancers. In this review, a basic introduction to ADAR structure and target recognition will be provided before summarizing how ADARs affect the fate of cellular RNAs and how researchers are using this knowledge to engineer ADARs for personalized medicine. In addition, we will highlight the important roles of ADARs and RNA editing in innate immunity and cancer biology.Entities:
Keywords: ADAR; Double-stranded RNA (dsRNA); RNA editing; RNA modification; cancer; dsRBP; innate immunity; inosine
Mesh:
Substances:
Year: 2020 PMID: 33356612 PMCID: PMC8019592 DOI: 10.1080/10409238.2020.1856768
Source DB: PubMed Journal: Crit Rev Biochem Mol Biol ISSN: 1040-9238 Impact factor: 8.250